Recently, a systematic pan‐cancer analysis using a variety of bioinformatic ways concludes that IGSF10 could serve as a novel prognostic marker and attainable immunotherapy for several malignancies, including lung cancer [15]. Here, IGSF10 is linked to lung cancer.